Business

A cannabinoids company backed by David Beckham will this week become the first company of its kind to formally unveil plans for a main London stock market debut. Sky News can exclusively reveal that Cellular Goods, which makes skincare and athletic recovery products manufactured from biosynthetic cannabinoids, will announce its intention to float as soon
0 Comments
A UK-based pharmaceutical firm that specialises in a cannabis-derived treatment for epilepsy has agreed to be bought in a $7.2bn (£5.3bn) takeover. GW Pharmaceuticals said the cash and stock deal with Jazz Pharmaceuticals – best known for its portfolio of sleep medicines – would create a neuroscience therapy powerhouse. The deal will allow Jazz, which
0 Comments
The FTSE-100 oil giant Shell will this week clinch the purchase of the Post Office’s broadband operations, transforming its presence in the UK home communications market. Sky News understands that Shell was on Sunday close to signing the deal after weeks of talks. It is expected to cost the energy behemoth in the region of
0 Comments
Financial markets have been rocked this week by a battle initiated by ordinary people against those who are usually dubbed market manipulators – hedge funds. This is not being fought on trading floors but online and is a consequence of an explosion in the popularity of amateur share trading by armchair investors and collaboration among
0 Comments